Alnylam Pharmaceuticals | Gewinn Vor Steuern



Pre Tax Profit Veränderung Datum
Acadia Pharmaceuticals USD 27.78M 133.31M 2025-03
Agios Pharmaceuticals USD -89289000 16.11M 2025-03
Alnylam Pharmaceuticals USD -35358000 6.24M 2025-06
Amgen USD 3.38B 111M 2024-12
Arrowhead Research USD 369.62M 544.73M 2025-03
BioMarin Pharmaceutical USD 169.64M 35.2M 2024-12
Incyte USD 558.01M 323.82M 2025-06
Ionis Pharmaceuticals USD 124M 271M 2025-06
Moderna USD -964000000 220M 2025-03
Neurocrine Biosciences USD 159.5M 144.8M 2025-06
Novartis USD 4.66B 269M 2024-12
PTC Therapeutics USD -94699000 3.29M 2024-12
Regeneron Pharmaceuticals USD 905M 53.1M 2025-03
Sanofi USD 2.32B 2.64B 2024-12
Sarepta Therapeutics USD -383518000 555.26M 2025-03
Takeda JPY 150.63B 257.93B 2025-06
Tectonic Therapeutic USD -17716000 5.02M 2024-09
Ultragenyx Pharmaceutical USD -133404000 191K 2024-12
Vertex Pharmaceuticals USD 1.32B 109.7M 2024-12
Xencor USD -48265000 4.36M 2025-03


Alnylam Pharmaceuticals Gewinn Vor Steuern - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.